Related Experiment Video
Updated: Jul 2, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Short-coupled variant of torsade de pointes
K Bogaard1, M S van der Steen, H L Tan
1Department of Cardiology, Kennemer Gasthuis, Haarlem, the Netherlands.
A rare form of ventricular tachycardia, short-coupled Torsade de Pointes, was managed with Verapamil. An implantable cardioverter-defibrillator is recommended due to persistent sudden death risk.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Primary sclerosing cholangitis and epilepsy are significant comorbidities.
- Cholangitis precipitated a critical cardiac event.
Purpose of the Study:
- To report a rare case of short-coupled Torsade de Pointes (TdP).
- To discuss management strategies for this specific arrhythmia.
Main Methods:
- Electrocardiogram (ECG) monitoring to identify ventricular premature beats (VPBs) and TdP.
- Pharmacological intervention with Verapamil.
- Assessment of arrhythmia suppression and sudden death risk.
Main Results:
- Frequent Torsade de Pointes (TdP) occurred, necessitating 12 defibrillations.
- Verapamil effectively suppressed the ventricular arrhythmia.
- Sudden death risk remained elevated despite Verapamil therapy.
Conclusions:
- Short-coupled TdP is a rare variant of polymorphic ventricular tachycardia with an unclear cause.
- Verapamil can suppress TdP but does not mitigate the risk of sudden cardiac death.
- Implantable cardioverter-defibrillator (ICD) implantation is advised for patients with short-coupled TdP.
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Dysrhythmias II: Classification of Tachyarrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias